Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab

被引:0
作者
Sakaguchi, Hiroyuki [1 ]
Tanimoto, Azusa [1 ]
Sato, Shigeki [1 ]
Yanagimura, Naohiro [1 ]
Suzuki, Chiaki [1 ]
Takumi, Yohei [1 ]
Nishiyama, Akihiro [1 ]
Yamashita, Kaname [1 ]
Takeuchi, Shinji [1 ]
Ohtsubo, Koshiro [1 ]
Yano, Seiji [1 ,2 ]
机构
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa, Japan
[2] Kanazawa Univ, WPI Nano Life Sci Inst WPI Nano LSI, Kanazawa, Ishikawa, Japan
关键词
mediastinal tumor; malignant melanoma; nivolumab; immunotherapy; IPILIMUMAB;
D O I
10.2169/internalmedicine.7452-21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary malignant melanoma (MM) of the mediastinum is rare, and there is a lack of consensus regarding the preferred treatment because non-cutaneous MM demonstrates an inferior response to systemic therapy. Herein, we describe the case of a 73-year-old man with MM of the anterior mediastinum with multiple liver metastases. Even though the size of lesions increased rapidly following diagnosis, nivolumab monotherapy caused remarkable tumor shrinkage. This is the first report of mediastinal MM showing a significant response to nivolumab. We, therefore, suggest that immunotherapy may be one of the treatment options for primary mediastinal MM.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 11 条
  • [1] Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation
    Bae, Hyun-Mi
    Lee, Jeong-Hoon
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    Heo, Dae Seog
    Lee, Hyo-Suk
    [J]. BMC CANCER, 2011, 11
  • [2] Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
    D'Angelo, Sandra P.
    Larkin, James
    Sosman, Jeffrey A.
    Lebbe, Celeste
    Brady, Benjamin
    Neyns, Bart
    Schmidt, Henrik
    Hassel, Jessica C.
    Hodi, F. Stephen
    Lorigan, Paul
    Savage, Kerry J.
    Miller, Wilson H., Jr.
    Mohr, Peter
    Marquez-Rodas, Ivan
    Charles, Julie
    Kaatz, Martin
    Sznol, Mario
    Weber, Jeffrey S.
    Shoushtari, Alexander N.
    Ruisi, Mary
    Jiang, Joel
    Wolchok, Jedd D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) : 226 - +
  • [3] Six cases of metastatic malignant melanoma with apparently occult primary lesions
    Honda, S
    Yamamoto, O
    Suenaga, Y
    Asahi, M
    Nakayama, K
    [J]. JOURNAL OF DERMATOLOGY, 2001, 28 (05) : 265 - 271
  • [4] A diagnostic approach to the mediastinal masses
    Juanpere, Sergi
    Canete, Noemi
    Ortuno, Pedro
    Martinez, Sandra
    Sanchez, Gloria
    Bernado, Lluis
    [J]. INSIGHTS INTO IMAGING, 2013, 4 (01): : 29 - 52
  • [5] Primary malignant melanoma: A rare cause of mediastinal mass
    Karuppiah S.V.
    Buchan K.G.
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 2006, 54 (9): : 396 - 398
  • [6] The clinical features, treatment, and prognosis of primary mediastinal malignant melanoma A case report
    Li, ZiHai
    Jia, Hui
    Zhang, Baijiang
    Zhang, Yongming
    Li, Hui
    Song, Pingping
    [J]. MEDICINE, 2017, 96 (17)
  • [7] Primary Malignant Melanoma of the Mediastinum: Radiologic and Pathologic Correlation in Two Case
    Park, Sun-Young
    Kim, Mi Young
    Chae, Eun Jin
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2012, 13 (06) : 823 - 826
  • [8] Anterior mediastinal tumors: Diagnostic accuracy of CT and MRI
    Tomiyama, Noriyuki
    Honda, Osamu
    Tsubamoto, Mitsuko
    Inoue, Atsuo
    Sumikawa, Hiromitsu
    Kuriyama, Keiko
    Kusumoto, Masahiko
    Johkoh, Takeshi
    Nakamura, Hironobu
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2009, 69 (02) : 280 - 288
  • [9] Hepatocellular Carcinoma With Extrahepatic Metastasis Clinical Features and Prognostic Factors
    Uchino, Koji
    Tateishi, Ryosuke
    Shiina, Shuichiro
    Kanda, Miho
    Masuzaki, Ryota
    Kondo, Yuji
    Goto, Tadashi
    Omata, Masao
    Yoshida, Haruhiko
    Koike, Kazuhiko
    [J]. CANCER, 2011, 117 (19) : 4475 - 4483
  • [10] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
    Wolchok, J. D.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Rutkowski, P.
    Grob, J. -J.
    Cowey, C. L.
    Lao, C. D.
    Wagstaff, J.
    Schadendorf, D.
    Ferrucci, P. F.
    Smylie, M.
    Dummer, R.
    Hill, A.
    Hogg, D.
    Haanen, J.
    Carlino, M. S.
    Bechter, O.
    Maio, M.
    Marquez-Rodas, I.
    Guidoboni, M.
    McArthur, G.
    Lebbe, C.
    Ascierto, P. A.
    Long, G. V.
    Cebon, J.
    Sosman, J.
    Postow, M. A.
    Callahan, M. K.
    Walker, D.
    Rollin, L.
    Bhore, R.
    Hodi, F. S.
    Larkin, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) : 1345 - 1356